Similar articles

• Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa.

  Monteleone P, Santonastaso P, Tortorella A, Favaro A, Fabrazzo M, Castaldo E, Caregaro L, Fuschino A, Maj M. Monteleone P, et al. Mol Psychiatry. 2005 Aug;10(8):716-8. doi: 10.1038/sj.mp.4001683. Mol Psychiatry. 2005. PMID: 15940301 No abstract available.
• Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa.

  Di Bella DD, Catalano M, Cavallini MC, Riboldi C, Bellodi L. Di Bella DD, et al. Mol Psychiatry. 2000 May;5(3):233-4. doi: 10.1038/sj.mp.4000689. Mol Psychiatry. 2000. PMID: 10889521 No abstract available.
• Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.

  Putzhammer A, Schoeler A, Rohrmeier T, Sand P, Hajak G, Eichhammer P. Putzhammer A, et al. Psychopharmacology (Berl). 2005 Mar;178(2-3):303-8. doi: 10.1007/s00213-004-1995-3. Epub 2004 Aug 18. Psychopharmacology (Berl). 2005. PMID: 15322730
• Eating disorders, serotonin transporter polymorphisms and potential treatment response.

  Gorwood P. Gorwood P. Am J Pharmacogenomics. 2004;4(1):9-17. doi: 10.2165/00129785-200404010-00002. Am J Pharmacogenomics. 2004. PMID: 14987118 Review.
• Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.

  Weizman A, Weizman R. Weizman A, et al. Pharmacogenomics. 2000 Aug;1(3):335-41. doi: 10.1517/14622416.1.3.335. Pharmacogenomics. 2000. PMID: 11256582 Review.